Researchers aim to develop techniques to manipulate molecular machinery of immune system

University of Arizona assistant professor is named Pew biomedical researcher of the month

WHAT:Immunobiologist Michael Kuhns, Ph.D.is The Pew Charitable Trusts' biomedical researcher of the month for his creative work on immunobiology. He studies T cell activation and regulation.

Kuhns aims to decode the "conversations" that take place between those immune cells and other cells in the human body as they work together to respond to infections, vaccines, and growing tumors. His long-term research goal is to develop techniques to manipulate the molecular machinery of the immune system for a desired outcome, such as enhancing response to vaccines or developing therapies to fight tumors.

Kuhns' story is the latest in Pew's biomedical researcher of the month series. Since 1985, the institution's biomedical programs have provided funding to more than 500 early-career investigators who, like Kuhns, show outstanding promise in science with the potential to advance human health. The scholars' exceptional research has earned them Nobel prizes, Lasker awards, MacArthur Foundation "genius" grants and other distinctions.

WHO:Experts are available for interviews regarding Kuhns' research and the program:

  • Michael Kuhns, Ph.D., 2011 Pew scholar and assistant professor, Department of Cell Immunobiology, University of Arizona College of Medicine
  • Anita Pepper, Ph.D., director of the Pew programs in the biomedical sciences

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients